PSILOCYBIN ANALOGS, SALTS, COMPOSITIONS, AND METHODS OF USE

The present disclosure relates to psilocin compounds and pharmaceutically acceptable salts, polymorphs, stereoisomers, or solvates thereof, to pharmaceutical compositions, and in some embodiments, to serotonin 5-HT2 receptor agonists and uses in the treatment of diseases associated with a 5-HT2 rece...

Full description

Saved in:
Bibliographic Details
Main Authors PATHARE, PRADIP, PALFREYMAN, MICHAEL, AVERY, KENNETH L, HUANG, JAMES HE, KRAKOWSKY, JOAN M, NIVOROZHKIN, ALEX, SHUKOOR, MOHAMMED, MORGAN, MICHAEL E
Format Patent
LanguageEnglish
French
Published 02.09.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to psilocin compounds and pharmaceutically acceptable salts, polymorphs, stereoisomers, or solvates thereof, to pharmaceutical compositions, and in some embodiments, to serotonin 5-HT2 receptor agonists and uses in the treatment of diseases associated with a 5-HT2 receptor. La présente invention concerne des composés psilocine et des sels, polymorphes, stéréoisomères, ou solvates pharmaceutiquement acceptables de ceux-ci, des compositions pharmaceutiques, et dans certains modes de réalisation, des agonistes du récepteur 5-HT 2 de la sérotonine et leurs utilisations dans le traitement de maladies associées à un récepteur 5-HT 2.
Bibliography:Application Number: CA20223212563